EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis

Gisli G Einarsson, Andrew J Lee, Peter J Barry, Hafsa Nauman, Rosemary Maher, Paul S McNamara, Jaclyn A Smith, Andrew M Jones, Michael M Tunney, Robert W Lord

Journal of Cystic Fibrosis · 2026-03 · 25 (2) · 225-231

DOI: 10.1016/j.jcf.2025.12.020 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cystic Fibrosis, 2026-03. Verfasst von Gisli G Einarsson und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy. Queen's University Belfast, Belfast United Kingdom, BT9 7BL. Hauptthemen laut MEDLINE: Cystic Fibrosis, Sputum, Microbiota, Oropharynx. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manchester Clinical Research Facility, Manchester Biomedical Research Centre, Vertex Pharmaceuticals Incorporated.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sputum analysis is the standard method for microbiological surveillance in cystic fibrosis (CF). However, CFTR modulator therapy has markedly reduced sputum production, creating an urgent need to evaluate alternative sampling strategies. Upper airway sampling has been proposed as a potential surrogate, but its ability to reflect the lower airway microbiota remains unclear. This study evaluated whether upper airway microbiota profiling can reliably represent the lower airway in adults with CF. In this prospective observational study, we compared the airway microbiota of 70 adults with CF and 10 healthy volunteers using oropharyngeal rinse (OPR) and sputum samples. Microbiota profiling was performed using 16S rRNA gene sequencing, with alpha- and beta-diversity, taxonomic composition, and divergence from healthy controls assessed for both sample types. The OPR and sputum microbiota of adults with CF were compositionally distinct, whereas healthy volunteers exhibited highly similar communities between sample types. Firmicutes dominated within OPR samples, while Proteobacteria, particularly Pseudomonas, predominated in sputum. Only 3 of 52 awCF who had Pseudomonas detected in sputum showed detectable, low-level OPR signals. Both sample types became increasingly dysbiotic with worsening lung function, reflecting greater deviation from healthy community structure. Although dysbiosis correlated across sample types, the divergence between upper and lower airways did not relate to lung function. These findings indicate that OPR sampling does not reliably identify key lower-airway pathogens. However, the association between OPR and lung function suggests that upper-airway sampling may reflect the degree of lower-airway dysbiosis, warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisSputumMicrobiotaOropharynxSpecimen HandlingHumansMaleFemaleAdultProspective StudiesReproducibility of ResultsRNA, Ribosomal, 16S

Stichwörter der Autor:innen

Cystic fibrosisLower respiratory tractMicrobiotaUpper respiratory tract

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • School of Pharmacy. Queen's University Belfast, Belfast United Kingdom, BT9 7BL.
  • Manchester Adult CF Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M23 9LT; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, M…
  • Manchester Adult CF Centre, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M23 9LT.
  • Centre for Proteome Research, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB.
  • Department of Child Health, Institute in the Park (University of Liverpool), Alder Hey Children's NHS Foundation Trust, Liverpool, L12 2AP.
  • Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, M13 9PL; Department of Respiratory Medicine, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manch…

Förderung

  • Manchester Clinical Research Facility
  • Manchester Biomedical Research Centre
  • Vertex Pharmaceuticals Incorporated
  • National Institute for Health and Care Research
  • Wellcome

Zitieren

APA

Einarsson, G. G., Lee, A. J., Barry, P. J., Nauman, H., Maher, R., McNamara, P. S., Smith, J. A., Jones, A. M., Tunney, M. M., & Lord, R. W. (2026). Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis. Journal of Cystic Fibrosis, 25(2), 225-231. https://doi.org/10.1016/j.jcf.2025.12.020

Vancouver

Einarsson GG, Lee AJ, Barry PJ, Nauman H, Maher R, McNamara PS, et al. Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis. Journal of Cystic Fibrosis. 2026;25(2):225-231. doi:10.1016/j.jcf.2025.12.020

BibTeX
@article{Einarsson2026,
  author = {Einarsson, Gisli G and Lee, Andrew J and Barry, Peter J and Nauman, Hafsa and Maher, Rosemary and McNamara, Paul S and Smith, Jaclyn A and Jones, Andrew M and Tunney, Michael M and Lord, Robert W},
  title = {Assessing the reliability of upper airway sampling for microbiological surveillance in cystic fibrosis},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  volume = {25},
  number = {2},
  pages = {225--231},
  doi = {10.1016/j.jcf.2025.12.020}
}
Kostenlos starten →